Armstrong L

Dimmick I

Dzierzak E

Forrester L

Krassowska A

Lako M

Lang R

Ledran MH

Oostendorp RAJ

Renstrom J

Santibanez-Coref M

Stojkovic M

Yung S

Hematopoietic stem cells derived from human embryonic stem cells (hESCs) could provide a therapeutic alternative to bone marrow transplants, but the efficiency of currently available derivation protocols is low. In this study, we investigated whether coculture with monolayers; of cells derived from mouse AGM and fetal liver, or with stromal cell lines derived from these tissues, can enhance hESC hematopoietic differentiation. We found that under such conditions hESC-derived differentiating cells formed early hematopoietic progenitors, with a peak at day 18-21 of differentiation that corresponded to the highest CD34 expression. These hESC-derived hematopoietic cells were capable of primary and secondary hematopoietic engraftment into immunocompromised mice at substantially higher levels than described previously. Transcriptional and functional analysis identified TGF-beta 1 and TGF-beta 3 as positive enhancers of hESC hematopoietic differentiation that can further stimulate this process when added to the culture. Overall, our findings represent significant progress toward the goal of deriving functional hematopoietic stem cells from hESCs

Newcastle University E-Prints

Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches

Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches

Abstract

Similar works

Full text

Available Versions

Newcastle University E-Prints